About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Clock
clock circadian regulator
MGI:99698
97 phenotypes from 7 alleles in 16 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Clockem1(IMPC)Ccpcz/Clockem1(IMPC)Ccpcz
C57BL/6NCrl-Clockem1(IMPC)Ccpcz/Ccpcz
abnormal skin morphology J:211773
abnormal thymus morphology J:211773
abnormal tooth morphology J:211773
decreased CD8-positive, naive alpha-beta T cell number J:211773
decreased circulating serum albumin level J:211773
decreased circulating total protein level J:211773
decreased effector memory T-helper cell number J:211773
decreased heart rate J:211773
decreased lung compliance J:211773
decreased red blood cell distribution width J:211773
decreased spleen weight J:211773
enlarged thymus J:211773
increased CD4-positive, alpha-beta T cell number J:211773
increased circulating alkaline phosphatase level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
increased eosinophil cell number J:211773
increased leukocyte cell number J:211773
increased lung elastance J:211773
increased lymphocyte cell number J:211773
increased T-helper cell number J:211773
Clockm1Btlr/Clockm1Btlr
C57BL/6J-Clockm1Btlr
increased body weight J:264640
Clockm1Jt/Clock+
B6(C)-Clockm1Jt
prolonged circadian behavior period J:198519
Clockm1Jt/Clock+
C57BL/6-Clockm1Jt
abnormal behavior J:101849
abnormal circadian behavior phase J:98343
abnormal sleep duration J:65198
abnormal sleep pattern J:65198
increased exploration in new environment J:101849
increased vertical activity J:101849
prolonged circadian behavior period J:18005, J:198519
Clockm1Jt/Clock+
involves: C57BL/6
abnormal circulating protein level J:155089
abnormal response to injury J:155089
Clockm1Jt/Clockm1Jt
C57BL/6-Clockm1Jt
abnormal basal metabolism J:98343
abnormal behavior J:101849
abnormal circadian behavior J:65198
abnormal circadian behavior persistence J:18005
abnormal circadian behavior phase J:98343
abnormal circadian regulation of heart rate J:125921
abnormal circadian regulation of systemic arterial blood pressure J:125921
abnormal circadian sleep/wake cycle J:65198
abnormal eating behavior J:98343
abnormal food intake J:98343
abnormal hepatocyte physiology J:98343
abnormal locomotor circadian rhythm J:98343
abnormal sleep duration J:65198
abnormal sleep pattern J:65198
decreased circulating corticosterone level J:98343
decreased energy expenditure J:98343
decreased heart rate J:125921
hepatic steatosis J:98343
hyperactivity J:98343, J:101849
increased body weight J:98343
increased circulating cholesterol level J:98343
increased circulating glucose level J:98343
increased circulating leptin level J:98343
increased circulating triglyceride level J:98343
increased exploration in new environment J:101849
increased fat cell size J:98343
increased percent body fat/body weight J:98343
increased susceptibility to diet-induced obesity J:98343
increased vertical activity J:101849
prolonged circadian behavior period J:18005
Clockm1Jt/Clockm1Jt
C57BL/6J-Clockm1Jt/J
abnormal enterocyte physiology J:153782
abnormal intestinal absorption J:153782
abnormal intestinal lipid absorption J:153782
increased intestinal glucose absorption J:153782
Clockm1Jt/Clockm1Jt
involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR
decreased physiological sensitivity to xenobiotic J:128504
Clockm1Jt/Clockm1Jt
involves: BALB/cJ * C57BL/6
arrhythmic circadian behavior persistence J:18005
normal nervous system phenotype J:18005
prolonged circadian behavior period J:18005
Clockm1Jt/Clockm1Jt
involves: BALB/cJ * C57BL/6 * C57BL/6J
abnormal medium spiny neuron morphology J:166742
abnormal nervous system electrophysiology J:166742
abnormal nucleus accumbens morphology J:166742
Clockm1Jt/Clockm1Jt
involves: C57BL/6
abnormal circadian behavior J:40363
abnormal circadian behavior phase J:99868
abnormal glucose homeostasis J:131694
abnormal lipid homeostasis J:131694
abnormal luteinizing hormone level J:92343
abnormal parturition J:92343
abnormal pregnancy J:92343
abnormal response to new environment J:99868
abnormal single cell response J:99868
decreased circulating estradiol level J:92343
decreased circulating luteinizing hormone level J:92343
decreased circulating progesterone level J:92343
decreased physiological sensitivity to xenobiotic J:92343
enhanced behavioral response to cocaine J:99868
hyperactivity J:99868
impaired gluconeogenesis J:131694
increased circulating estradiol level J:92343
increased circulating progesterone level J:92343
increased insulin sensitivity J:131694
increased vertical activity J:99868
prolonged circadian behavior period J:40363
prolonged estrous cycle J:92343
prolonged estrus J:92343
normal reproductive system phenotype J:92343
short proestrus J:92343
Clockm1Jt/Clockm1Jt
involves: C57BL/6 * C57BL/6J
abnormal hair cycle J:151782
abnormal hair cycle anagen phase J:151782
Clockm1Jt/Clockm1Jt
involves: C57BL/6 * C57BL/6J * Jcl:ICR
abnormal circadian behavior J:125037
abnormal circadian behavior phase J:125037
Clockm1Jt/Clockm1Jt
involves: C57BL/6 * Jcl:ICR
abnormal circadian behavior J:103663, J:116792
abnormal circadian sleep/wake cycle J:103663, J:116792
abnormal circadian temperature homeostasis J:103663, J:116792
abnormal sleep duration J:103663
abnormal sleep pattern J:103663
abnormal spatial learning J:116792
normal behavior/neurological phenotype J:116792
hyperactivity J:116792
increased vertical activity J:116792
Clockm1Jt/Clockm1Jt
involves: C57BL/6J
abnormal pancreas physiology J:162641
abnormal pancreatic islet morphology J:162641
decreased insulin secretion J:162641
hyperglycemia J:162641
impaired glucose tolerance J:162641
increased insulin sensitivity J:162641
increased pancreatic islet cell apoptosis J:162641
insulin resistance J:162641
small pancreatic islets J:162641
Clocktm1.1Rep/Clocktm1.1Rep
involves: 129S4/SvJae * C57BL/6J
abnormal circadian behavior phase J:109634
advanced circadian behavior phase J:109634
Clocktm1Jt/Clocktm1Jt
B6.Cg-Clocktm1Jt
no abnormal phenotype detected J:101977
Tg(Scg2-tTA)1Jt/0
Tg(tetO-Clock)1Jt/0
involves: C57BL/6J * CD-1
shortened circadian behavior period J:120326
Tg(Scg2-tTA)1Jt/0
Tg(tetO-Clockm1Jt)CL57Jt/0
involves: C57BL/6J * CD-1
abnormal circadian behavior phase J:120326
abnormal locomotor circadian rhythm J:120326
delayed circadian behavior phase J:120326
prolonged circadian behavior period J:120326

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory